These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

258 related articles for article (PubMed ID: 26280580)

  • 21. CHARGE and Kabuki syndromes: a phenotypic and molecular link.
    Schulz Y; Freese L; Mänz J; Zoll B; Völter C; Brockmann K; Bögershausen N; Becker J; Wollnik B; Pauli S
    Hum Mol Genet; 2014 Aug; 23(16):4396-405. PubMed ID: 24705355
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Absence of deletion and duplication of MLL2 and KDM6A genes in a large cohort of patients with Kabuki syndrome.
    Priolo M; Micale L; Augello B; Fusco C; Zucchetti F; Prontera P; Paduano V; Biamino E; Selicorni A; Mammì C; Laganà C; Zelante L; Merla G
    Mol Genet Metab; 2012 Nov; 107(3):627-9. PubMed ID: 22840376
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Kabuki syndrome: expanding the phenotype to include microphthalmia and anophthalmia.
    McVeigh TP; Banka S; Reardon W
    Clin Dysmorphol; 2015 Oct; 24(4):135-9. PubMed ID: 26049589
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The histone methyltransferase KMT2D, mutated in Kabuki syndrome patients, is required for neural crest cell formation and migration.
    Schwenty-Lara J; Nehl D; Borchers A
    Hum Mol Genet; 2020 Jan; 29(2):305-319. PubMed ID: 31813957
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A novel KMT2D mutation resulting in Kabuki syndrome: A case report.
    Lu J; Mo G; Ling Y; Ji L
    Mol Med Rep; 2016 Oct; 14(4):3641-5. PubMed ID: 27573763
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Neurobehavioral features in individuals with Kabuki syndrome.
    Caciolo C; Alfieri P; Piccini G; Digilio MC; Lepri FR; Tartaglia M; Menghini D; Vicari S
    Mol Genet Genomic Med; 2018 May; 6(3):322-331. PubMed ID: 29536651
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [One novel pathologic variation in
    Qiu SW; Yuan YY
    Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2019 Sep; 33(9):820-824. PubMed ID: 31446696
    [No Abstract]   [Full Text] [Related]  

  • 28. Kabuki syndrome: novel pathogenic variants, new phenotypes and review of literature.
    Shangguan H; Su C; Ouyang Q; Cao B; Wang J; Gong C; Chen R
    Orphanet J Rare Dis; 2019 Nov; 14(1):255. PubMed ID: 31727177
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Hypermobility in individuals with Kabuki syndrome: The effect of growth hormone treatment.
    Schott DA; Stumpel CTRM; Klaassens M
    Am J Med Genet A; 2019 Feb; 179(2):219-223. PubMed ID: 30556359
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Kabuki syndrome revisited.
    Bokinni Y
    J Hum Genet; 2012 Apr; 57(4):223-7. PubMed ID: 22437206
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Autism spectrum disorder in Kabuki syndrome: clinical, diagnostic and rehabilitative aspects assessed through the presentation of three cases.
    Parisi L; Di Filippo T; Roccella M
    Minerva Pediatr; 2015 Aug; 67(4):369-75. PubMed ID: 26129805
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The defining DNA methylation signature of Kabuki syndrome enables functional assessment of genetic variants of unknown clinical significance.
    Aref-Eshghi E; Schenkel LC; Lin H; Skinner C; Ainsworth P; Paré G; Rodenhiser D; Schwartz C; Sadikovic B
    Epigenetics; 2017; 12(11):923-933. PubMed ID: 28933623
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Recurrent giant cell fibroblastoma: Malignancy predisposition in Kabuki syndrome revisited.
    Karagianni P; Lambropoulos V; Stergidou D; Fryssira H; Chatziioannidis I; Spyridakis I
    Am J Med Genet A; 2016 May; 170A(5):1333-8. PubMed ID: 26898171
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Inhibition of Notch signaling rescues cardiovascular development in Kabuki Syndrome.
    Serrano MLA; Demarest BL; Tone-Pah-Hote T; Tristani-Firouzi M; Yost HJ
    PLoS Biol; 2019 Sep; 17(9):e3000087. PubMed ID: 31479440
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cancer Management in Kabuki Syndrome: The First Case of Wilms Tumor and a Literature Review.
    Teranishi H; Koga Y; Nakashima K; Morihana E; Ishii K; Sakai Y; Taguchi T; Oda Y; Miyake N; Matsumoto N; Ohga S
    J Pediatr Hematol Oncol; 2018 Jul; 40(5):391-394. PubMed ID: 29489735
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Clinical and molecular characterization study of Chinese Kabuki syndrome in Hong Kong.
    So PL; Luk HM; Yu KPT; Cheng SSW; Hau EWL; Ho SKL; Lam STS; Lo IFM
    Am J Med Genet A; 2021 Mar; 185(3):675-686. PubMed ID: 33314698
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Kabuki syndrome: clinical and molecular diagnosis in the first year of life.
    Dentici ML; Di Pede A; Lepri FR; Gnazzo M; Lombardi MH; Auriti C; Petrocchi S; Pisaneschi E; Bellacchio E; Capolino R; Braguglia A; Angioni A; Dotta A; Digilio MC; Dallapiccola B
    Arch Dis Child; 2015 Feb; 100(2):158-64. PubMed ID: 25281733
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Clinical and molecular characteristics of Korean patients with Kabuki syndrome.
    Yoon JH; Hwang S; Bae H; Kim D; Seo GH; Koh JY; Ju YS; Do HS; Kim S; Kim GH; Kim JH; Choi JH; Lee BH
    J Hum Genet; 2024 Sep; 69(9):417-423. PubMed ID: 38824232
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Kabuki Syndrome-Clinical Review with Molecular Aspects.
    Boniel S; Szymańska K; Śmigiel R; Szczałuba K
    Genes (Basel); 2021 Mar; 12(4):. PubMed ID: 33805950
    [TBL] [Abstract][Full Text] [Related]  

  • 40. De novo exonic deletion of KDM6A in a Chinese girl with Kabuki syndrome: A case report and brief literature review.
    Yang P; Tan H; Xia Y; Yu Q; Wei X; Guo R; Peng Y; Chen C; Li H; Mei L; Huang Y; Liang D; Wu L
    Am J Med Genet A; 2016 Jun; 170(6):1613-21. PubMed ID: 27028180
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.